English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  53224100    ???header.onlineuser??? :  1509
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shan y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-8 of 8  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2021-07 A phase I study of biweekly abraxane in combination with oxaliplatin and oral S-1/leucovorin as first line treatment for advanced gastric, pancreatic and biliary tract cancers Tsai, H;Yang, S;Hsiao, C;Kao, H;Shan, Y;Lin, Y;Yen, C;Du, J;Hsu, C;Wu, I;Chen, L
國家衛生研究院 2021-07 Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma Su, Y;Lin, Y;Hsiao, C;Ou, D;Chen, S;Wu, Y;Lee, W;Lin, J;Hsu, C;Ho, M;Lu, L;Wu, T;Lai, S;Chao, Y;Chou, T;Yen, C;Chen, L;Shan, Y;Cheng, A;Hsu, C
臺大學術典藏 2021-01-26T02:27:40Z TR4 nuclear receptor alters the prostate cancer CD133+ stem/progenitor cell invasion via modulating the EZH2-related metastasis gene expression Zhu J.;Yang D.-R.;Sun Y.;Qiu X.;Hong-Chiang Chang;Li G.;Shan Y.;Chang C.; Zhu J.; Yang D.-R.; Sun Y.; Qiu X.; HONG-CHIANG CHANG; Li G.; Shan Y.; Chang C.
國立交通大學 2014-12-08T15:06:31Z SHELL-MODEL STUDIES OF THE Y-90,ZR-91,NB-92 AND MO-93 NUCLEI CHUU, DS; YEN, MMK; SHAN, Y; HSIEH, ST
國家衛生研究院 2014-09 KRüPPEL like factor 10 modulates radio-sensitivity by transcriptionally regulating UV radiation resistance associated gene in pancreatic cancer Chang, H;Tsai, Y;Chang, VH;Yu, WC;Peng, S;Shan, Y;Li, C
國立成功大學 2014-09 KRuPPEL LIKE FACTOR 10 MODULATES RADIO-SENSITIVITY BY TRANSCRIPTIONALLY REGULATING UV RADIATION RESISTANCE ASSOCIATED GENE IN PANCREATIC CANCER Chang, H.; Tsai, Y.; Chang, V.H.; Yu, W.C.; Peng, S.; Shan, Y.; Li, C.
國家衛生研究院 2011-02 A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer Ko, AH;Tempero, MA;Shan, Y;Su, W;Lin, Y;Dito, E;Ong, A;Yeh, G;Chen, L
國家衛生研究院 2009-05-20 A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study Ch'ang, H;Hwang, T;Wang, H;Chang, M;Tien, Y;Chen, J;Hsieh, R;Lin, P;Shan, Y;Cheng, A;Chen, L

Showing items 1-8 of 8  (1 Page(s) Totally)
1 
View [10|25|50] records per page